|
|
|
|
Tuesday, 20 January 2026 |
|
|
|
|
|
|
What we picked up on from JPM (from afar) |
|
|
| The Health Tech team didn’t attend this year’s JP Morgan Healthcare Conference in San Francisco, but we did our best to figure out what the talk of the town was. There’s no doubt that the weeklong meeting sets the tone for what’s ahead across the healthcare industry, even though major health insurers have skipped presenting at the conference for the past two years. |
- The announcements from OpenAI and Anthropic, detailing their healthcare strategies in the days leading up to the event, made the biggest splash. I’d expect their moves to dictate a fair amount of what transpires this year as companies look to contend with the AI giants.
- We heard from our colleagues on the ground that the general sentiment of the conference was more optimistic and stronger this year than the past few.
- There was some volatility among the public health tech companies that presented. Progyny, for instance, fell 11% on the day of its presentation. Jefferies analyst Brian Tanquilut attributed the movement across health tech companies to “no news viewed as bad news.”
- The presentation we most wish we'd seen was by OpenEvidence, the startup using AI to answer doctors' clinical questions. And we weren’t the only ones, as it was reportedly a packed room.
- … and don’t miss Ngai’s latest on BetterHelp’s evolving relationship with AI, as mentioned on stage by Teladoc CEO Chuck Divita.
|
| - Lydia |
|
|
|
|
|
|
|
Health Tech’s public performance |
|
|
Despite the buzz from new 2025 IPOs, publicly traded health tech companies still lag behind the performance of the S&P 500, SVB found in its 2026 Healthcare Industry Trends report. And not surprisingly, SVB said AI represented 46%, or nearly $18 billion, of all healthcare (including biopharma, diagnostics and devices) deals in 2025. |
|
|
|
|
|
|
|
|
|
|
Worldwide made. Thanks for reading.
|
|
|
|
|
|
|
|
